RWS agrees £22.4 million Acogroup deal to expand its European AI client base

RWS Holdings has agreed to acquire Acogroup, the parent company of language and content services provider Acolad, in a deal carrying an enterprise value of £22.4 million.

The acquisition would considerably expand RWS's European enterprise client base. It also gives the company a fresh audience for AI products including its Cultural Intelligence Layer and Language Weaver Pro platform.

There is plenty of strategic logic here, particularly given Acolad's presence in regulated industries. The valuation also looks modest against the acquired company's expected earnings contribution.

However, investors should note that total consideration is higher than the headline enterprise value, completion remains subject to regulatory clearances, and important details such as integration costs and quantified synergies have not been disclosed.

The full details are available in the original company announcement.

RWS and Acogroup deal at a glance

Key figure	Detail
Enterprise value	£22.4 million
Total consideration	£40.2 million
Cash expected to be acquired	Approximately £17.8 million
Acolad 2025 revenue	£182 million
Acolad 2025 adjusted EBITDA	£13 million
Expected annualised FY27 revenue contribution	Approximately £155 million
Expected annualised FY27 adjusted EBITDA contribution	Approximately £11 million
Employees	Approximately 1,200
Countries of operation	22
Expected completion	H1 FY27 at the latest

Enterprise value is the implied value of the underlying operations after taking account of cash and debt. RWS will pay total consideration of £40.2 million, but expects to receive approximately £17.8 million of cash when the deal completes. This produces the stated £22.4 million enterprise value.

RWS also says it will not acquire any third-party debt as part of the transaction.

What RWS is buying

Founded in 1995 and headquartered near Paris, Acolad operates across 22 countries in Europe and North America. It employs approximately 1,200 people and has a particularly strong position in Western Europe.

Around 75% of revenue comes from localisation and related services. Localisation involves adapting content for different languages, markets and cultural expectations, rather than simply translating it word for word.

The remaining 25% comes from interpreting, transcription and other services. Interpreting is a new capability for RWS's portfolio and could create additional cross-selling opportunities across the enlarged group.

Acolad also works with approximately half of the companies in France's CAC 40 index. This is strategically useful because RWS wants to move towards larger, multi-year enterprise client relationships.

Following completion, Acolad will join RWS's Transform segment.

Why the acquisition could matter

The central attraction is not simply additional revenue. RWS believes it can sell more of its existing and next-generation technology to Acolad's clients.

That expanded customer base could increase the potential returns from RWS's investment in AI platforms. Products highlighted by management include the Cultural Intelligence Layer, Language Weaver Pro and the next-generation platforms being developed within Transform.

Acolad's customers could also gain access to RWS's Generate and Protect solutions. This gives the transaction a broader cross-selling case rather than relying entirely on cost reductions.

There is also a potentially useful sector fit. Approximately half of Acolad's revenue comes from regulated industries and public institutions. Its established medical devices business complements RWS's existing strength in the pharmaceutical segment of life sciences.

Regulated clients can place a high value on accuracy, governance and specialist knowledge. That appears consistent with RWS's strategy of combining AI with human language and subject expertise.

For more company-specific coverage, investors can follow the RWS Holdings PLC share page.

The valuation is an important part of the story

RWS says the £22.4 million enterprise value represents two times Acolad's expected adjusted EBITDA for the year ending 30 September 2027.

Adjusted EBITDA is earnings before interest, tax, depreciation and amortisation, with certain items removed. It is commonly used to compare operating performance, although it does not represent cash available to shareholders.

The low stated multiple creates scope for value if RWS can integrate Acolad successfully, retain its clients and deploy its technology across the acquired business.

There is a wrinkle in the numbers, though. Acolad generated revenue of £182 million and adjusted EBITDA of £13 million in 2025. Its expected annualised contribution in RWS's 2027 financial year is lower, at approximately £155 million of revenue and £11 million of adjusted EBITDA.

The announcement does not explain the expected reduction in detail. Investors will therefore want more information on Acolad's underlying trading trajectory when RWS provides its completion update.

Funding and completion conditions

RWS plans to fund the acquisition through its existing facilities. The company says it refinanced its revolving credit facility in October 2025 and remains well-capitalised, with strong cash generation.

The resulting level of group borrowings after completion was not disclosed. RWS also did not disclose expected integration costs, quantified cost savings, revenue synergies or the transaction's expected effect on earnings per share.

Completion is expected during the first half of RWS's 2027 financial year at the latest. Before that can happen, two Acolad subsidiaries must complete consultation processes with their French Works Councils.

The transaction also requires regulatory clearance from the French Ministry for the Economy, Finance and Industrial, Energy and Digital Sovereignty, alongside any other required foreign investment approvals.

This means the acquisition is agreed but not yet completed.

What investors should watch next

The deal offers RWS substantial additional scale for a relatively low stated enterprise value. Acolad brings established European relationships, regulated-industry exposure and an interpreting capability that RWS does not currently have in its portfolio.

The main test will be execution. RWS must turn access to Acolad's clients into genuine demand for its AI platforms while integrating approximately 1,200 employees across 22 countries.

Investors should watch for completion timing, regulatory approvals, the financing position and further detail on integration costs. An explanation for the lower expected annualised revenue and adjusted EBITDA contribution compared with Acolad's 2025 results would also be useful.

If RWS can retain the acquired client base and apply its technology playbook effectively, the £22.4 million enterprise value could prove attractive. For now, the strategic opportunity is clear, but the financial benefits beyond Acolad's expected contribution have not been quantified.